iiinova — where your digital self keeps evolving

I-Stem @i-stem.bsky.social · 28/09/2026

@univevry.bsky.social is opening a Junior Professorship position. The research activity will be carried out within team, "Neuroplasticity and Therapeutics" at I-Stem. We are therefore looking for the ideal candidate! @afm-telethon.bsky.social

000

I-Stem @i-stem.bsky.social · 25/09/2026

We highlight new research in @npjregenmed on non-destructive quality controls for hPSC-derived cell therapies, combining scRNA-seq & proteomics. Congrats to the authors and I-Stem & Proteom’IC contributors! @afm-telethon.bsky.social @univevry.bsky.social rdcu.be/rFYxPpEWdosa

rdcu.be

000

I-Stem @i-stem.bsky.social · 24/09/2026

Mise en lumière de l'excellence et de l'innovation à I-Stem dans Plug In Labs de @univevry.bsky.social ! O. Chose et son équipe, au sein de StemCare dirigée par A. Benchoua, accompagnent les chercheurs dans leurs développements. @inserm.fr @afm-telethon.bsky.social bit.ly/4jfbQWg

bit.ly

I-STEM / Plateforme de bioproduction - Genopole - Plug In Labs Paris Saclay

001

I-Stem @i-stem.bsky.social · 04/07/2026

The Drug Cell is hiring... and the position will be hosted by I-Stem ! = 2 reasons to be a part of our great scientific and technological challenge ! A fantastic post-doc level opportunity !! www.linkedin.com/jobs/view/44...

linkedin.com

The Drug Cell hiring Project leader – Induced Pluripotent Stem Cell (iPSC) Tolerance in Corbeil-Essonnes, Île-de-France, France | LinkedIn

Posted 3:49:18 PM. Duration: Long term contract Start date: september 2026Location: located at CECS…See this and similar jobs on LinkedIn.

010

I-Stem @i-stem.bsky.social · 29/06/2026

8 minutes pour tout comprendre sur les cellules souches !! radiofrance.fr/franceculture/… Merci à Christelle Montville et Camille Geiger d'avoir fait découvrir I-Stem et les projets de l'équipe rétinopathies à l'équipe de @franceculture.fr @afm-telethon.bsky.social @univevry.bsky.social

radiofrance.fr

000

I-Stem @i-stem.bsky.social · 07/05/2026

@xaviernissan.bsky.social et son équipe aide à évaluer un même traitement dans plusieurs maladies partageant un mécanisme biologique commun : une approche prometteuse des essais cliniques "basket" pour accélérer l'innovation thérapeutique. bit.ly/49hogXO @horizoneu.bsky.social @ec.europa.eu & HaDea

bit.ly

AI joins the quest to find new treatments for rare diseases

Belgian AI company Kantify was doing business as usual until a cancer diagnosis forced the team to rethink their direction. “We built algorithms for sectors like marketing or transport,” said Ségolène...

000

Reposted by I-Stem

LabEx Revive @labexrevive.bsky.social · 20/03/2026

Here we GO! High schools ready to talk about #stem #cell in @pasteur.fr, with Walter Habeler from @i-stem.bsky.social #unistemday2026

042

I-Stem @i-stem.bsky.social · 19/03/2026

IStem est heureux d’accompagner le lancement de cette nouvelle filière de thérapie cellulaire, The Drug Cell ! Magnifique dynamique de souveraineté sanitaire au service des patients ! 🇪🇺 🇫🇷👩‍🔬🧬💊 #frenchtech #therapiecellulaire #france2030 #thedrugcell

000

I-Stem @i-stem.bsky.social · 24/11/2025

Congratulations to Caroline, who received the Best Short Talk from Claire Rougeulle @institutcurie.bsky.social and Anne Camus @cnrs.fr at #FSSCR2025! Her talk highlighted how 3D neuromuscular models help uncover mechanisms involved in congenital dystrophic myotonia.

010